UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

Leukemia, 2009-11, Vol.23 (11), p.2147-2152

2009

Volltextzugriff (PDF)

Multi-locus DNA metabarcoding of zooplankton communities and scat reveal trophic interactions of a generalist predator

Scientific reports, 2019-01, Vol.9 (1), p.281-281, Article 281

2019

Volltextzugriff (PDF)

Recent clinical studies of the immunomodulatory drug (IMiD ) lenalidomide

British journal of cancer, 2005-09, Vol.93 (6), p.613-619

2005

Volltextzugriff (PDF)

Thalidomide as a novel therapeutic agent: new uses for an old product

Drug Discovery Today, 2005-01, Vol.10 (2), p.107-114

2005

Volltextzugriff (PDF)

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease

Gastroenterology (New York, N.Y. 1943), 1999-12, Vol.117 (6), p.1278-1287

1999

Volltextzugriff (PDF)

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

The New England journal of medicine, 1999-11, Vol.341 (21), p.1565-1571

1999

Volltextzugriff (PDF)

Biogeographic and trophic drivers of mesozooplankton distribution on the northeast continental shelf and in Hauraki Gulf, New Zealand

New Zealand journal of marine and freshwater research, 2015-01, Vol.49 (1), p.69-86

2015

Volltextzugriff (PDF)

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

Blood, 2002-11, Vol.100 (9), p.3063-3067

2002

Volltextzugriff (PDF)

An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast

Current medical research and opinion, 2008-05, Vol.24 (5), p.1529-1538

2008

Volltextzugriff (PDF)

Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients

Blood, 2001-07, Vol.98 (2), p.492-494

2001

Volltextzugriff (PDF)

Mesozooplankton community composition, feeding, and export production during SOIREE

Deep-sea research. Part II, Topical studies in oceanography, 2001, Vol.48 (11), p.2615-2634

Zeldis, John

2001

Volltextzugriff (PDF)

Snapper (Chrysophrys auratus): a review of life history and key vulnerabilities in New Zealand

New Zealand journal of marine and freshwater research, 2014-04, Vol.48 (2), p.256-283

2014

Volltextzugriff (PDF)

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers

British journal of cancer, 2004-03, Vol.90 (5), p.955-961

2004

Volltextzugriff (PDF)

Efficacy of Lenalidomide in Myelodysplastic Syndromes

The New England journal of medicine, 2005-02, Vol.352 (6), p.549-557

2005

Volltextzugriff (PDF)

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes

Blood, 2001-08, Vol.98 (4), p.958-965

2001

Volltextzugriff (PDF)

Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy

Annals of oncology, 2006-12, Vol.17 (12), p.1766-1771

2006

Volltextzugriff (PDF)

ENSO and riverine control of nutrient loading, phytoplankton biomass and mussel aquaculture yield in Pelorus Sound, New Zealand

Marine ecology. Progress series (Halstenbek), 2008-11, Vol.371, p.131-142

2008

Volltextzugriff (PDF)

Regenerated primary production dominates in a periodically upwelling shelf ecosystem, northeast New Zealand

Continental shelf research, 2012-01, Vol.32, p.1-21

2012

Volltextzugriff (PDF)

S.T.E.P.S. ™: A comprehensive program for controlling and monitoring access to thalidomide

Clinical therapeutics, 1999-02, Vol.21 (2), p.319-330

1999

Volltextzugriff (PDF)

First observations of predation by New Zealand Greenshell mussels ( Perna canaliculus) on zooplankton

Journal of experimental marine biology and ecology, 2004-11, Vol.311 (2), p.287-299

2004

Volltextzugriff (PDF)

Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide

Journal of thrombosis and haemostasis, 2006-08, Vol.4 (8), p.1842-1845

2006

Volltextzugriff (PDF)

Thalidomide in the treatment of leprosy

Microbes and Infection, 2002-09, Vol.4 (11), p.1193-1202

2002

Volltextzugriff (PDF)

Thalidomide for Patients With Relapsed Multiple Myeloma After High-Dose Chemotherapy and Stem Cell Transplantation: Results of an Open-Label Multicenter Phase 2 Study of Efficacy, Toxicity, and Biological Activity

Mayo Clinic proceedings, 2004-07, Vol.79 (7), p.875-882

2004

Volltextzugriff (PDF)

Influence of climate on Pelorus Sound mussel aquaculture yields: predictive models and underlying mechanisms

Aquaculture Environment Interactions, 2013-01, Vol.4 (1), p.1-15

2013

Volltextzugriff (PDF)

Comparative Pharmacodynamics and Plasma Concentrations of d-threo-Methylphenidate Hydrochloride After Single Doses of d-threo-Methylphenidate Hydrochloride and d,l-threo-Methylphenidate Hydrochloride in a Double-Blind, Placebo-Controlled, Crossover Laboratory School Study in Children With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child and Adolescent Psychiatry, 2004-11, Vol.43 (11), p.1422-1429

2004

Volltextzugriff (PDF)

1 – 25 von 263

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(223)

Publikationsform

Sprache

Englisch
(262)
Japanisch
(22)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(164)
Life Sciences & Biomedicine
(152)
Humans
(129)
Biological And Medical Sciences
(92)
Female
(79)
Male
(69)
Medical Sciences
(69)
Middle Aged
(60)
Adult
(59)
Aged
(49)
Thalidomide - Analogs & Derivatives
(32)
Physical Sciences
(30)
Thalidomide - Therapeutic Use
(30)
Marine
(29)
Thalidomide - Adverse Effects
(29)
General & Internal Medicine
(27)
Medicine, General & Internal
(26)
Pharmacology. Drug Treatments
(25)
Thalidomide - Administration & Dosage
(25)
Oceanography
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

Multi-locus DNA metabarcoding of zooplankton communities and scat reveal trophic interactions of a generalist predator

Recent clinical studies of the immunomodulatory drug (IMiD ) lenalidomide

Thalidomide as a novel therapeutic agent: new uses for an old product

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

Biogeographic and trophic drivers of mesozooplankton distribution on the northeast continental shelf and in Hauraki Gulf, New Zealand

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast

Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients

Mesozooplankton community composition, feeding, and export production during SOIREE

Snapper (Chrysophrys auratus): a review of life history and key vulnerabilities in New Zealand

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers

Efficacy of Lenalidomide in Myelodysplastic Syndromes

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes

Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy

ENSO and riverine control of nutrient loading, phytoplankton biomass and mussel aquaculture yield in Pelorus Sound, New Zealand

Regenerated primary production dominates in a periodically upwelling shelf ecosystem, northeast New Zealand

S.T.E.P.S. ™: A comprehensive program for controlling and monitoring access to thalidomide

First observations of predation by New Zealand Greenshell mussels ( Perna canaliculus) on zooplankton

Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide

Thalidomide in the treatment of leprosy

Thalidomide for Patients With Relapsed Multiple Myeloma After High-Dose Chemotherapy and Stem Cell Transplantation: Results of an Open-Label Multicenter Phase 2 Study of Efficacy, Toxicity, and Biological Activity

Influence of climate on Pelorus Sound mussel aquaculture yields: predictive models and underlying mechanisms

Suchergebnisse filtern